These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9481109)

  • 1. Hepatitis C virus infection in blood donors: to screen or not to screen?
    Anand AC; Dhot PS; Ohri VC
    Natl Med J India; 1997; 10(6):304-5. PubMed ID: 9481109
    [No Abstract]   [Full Text] [Related]  

  • 2. [Importance of introduction of PCR in blood banks].
    Gürtler L
    Infusionsther Transfusionsmed; 1996 Feb; 23(1):4-6. PubMed ID: 8653016
    [No Abstract]   [Full Text] [Related]  

  • 3. New Federal guidelines for hepatitis C virus lookback.
    Witthaus D
    MLO Med Lab Obs; 1998 Sep; 30(9):22-6. PubMed ID: 10186315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of transfusion associated infections in multitransfused children in relation to mandatory screening of HIV in donated blood.
    Aggarwal V; Prakash C; Yadav S; Chattopadhya D
    Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):699-706. PubMed ID: 9656388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of markers of transfusion transmissible diseases in voluntary and replacement blood donors.
    Sharma RR; Cheema R; Vajpayee M; Rao U; Kumar S; Marwaha N; Agnihotri SK
    Natl Med J India; 2004; 17(1):19-21. PubMed ID: 15115227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum pooling for screening of blood donors for hepatitis C virus antibody.
    Kini S; Kumar S; Sharma RR; Thakral B; Agnihotri SK
    Indian J Pathol Microbiol; 2003 Jul; 46(3):537-8. PubMed ID: 15025337
    [No Abstract]   [Full Text] [Related]  

  • 7. Current good manufacturing practice for blood and blood components; notification of consignees and transfusion recipients receiving blood and blood components at increased risk of transmitting hepatitis C virus infection ("lookback"). Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Aug; 72(164):48765-801. PubMed ID: 17886394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
    Singh B; Verma M; Verma K
    Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a general hepatitis C lookback program for persons who received blood transfusions in a neonatal intensive care unit between January 1975 and July 1992.
    Cagle HH; Jacob J; Homan CE; Williams JL; Christensen CJ; McMahon BJ
    Arch Pediatr Adolesc Med; 2007 Feb; 161(2):125-30. PubMed ID: 17283296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of transfusion-transmitted hepatitis C virus in a tertiary hospital in Nigeria.
    Imarengiaye CO; Enosolease ME; Iribhogbe PE; Ehigiegba AE
    Public Health; 2006 Mar; 120(3):274-8. PubMed ID: 16364383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of nucleic acid testing for blood donor screening of human immunodeficiency virus and hepatitis C virus in the Saudi population.
    Akhter J; Roberts GT; Perry A; Gaucher JS; Howman PA
    Saudi Med J; 2001 Dec; 22(12):1073-5. PubMed ID: 11802179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predonation testing of potential blood donors in resource-restricted settings.
    Owusu-Ofori S; Temple J; Sarkodie F; Candotti D; Allain JP
    Transfusion; 2005 Sep; 45(9):1542-3. PubMed ID: 16131391
    [No Abstract]   [Full Text] [Related]  

  • 13. Predonation testing of potential blood donors in resource-restricted settings.
    Gorlin JB
    Transfusion; 2005 Sep; 45(9):1541-2. PubMed ID: 16131390
    [No Abstract]   [Full Text] [Related]  

  • 14. Canadian Blood Services to screen for Chagas disease.
    Comeau P
    CMAJ; 2007 Jul; 177(3):242. PubMed ID: 17664439
    [No Abstract]   [Full Text] [Related]  

  • 15. Preventing transmission of hepatitis C.
    MacDonald M; Wodak A
    Aust Fam Physician; 2003 Oct; 32(10):799-803. PubMed ID: 14596074
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hepatitis C and ALT in blood donors].
    García Bueno MJ
    Sangre (Barc); 1991 Jun; 36(3):252-3. PubMed ID: 1948551
    [No Abstract]   [Full Text] [Related]  

  • 17. Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings.
    Owusu-Ofori S; Temple J; Sarkodie F; Anokwa M; Candotti D; Allain JP
    Transfusion; 2005 Feb; 45(2):133-40. PubMed ID: 15660820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C screening and notification: hospitals under new FDA regulations.
    Thomas M; Favata-Bosh DM
    QRC Advis; 1999 Jan; 15(3):1-5. PubMed ID: 10345516
    [No Abstract]   [Full Text] [Related]  

  • 19. Seroprevalence of hepatitis C virus among blood donors in Rivers State, Nigeria.
    Koate BB; Buseri FI; Jeremiah ZA
    Transfus Med; 2005 Oct; 15(5):449-51. PubMed ID: 16202063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiological information obtained from anti-hepatitis C virus screening in blood donors and candidates for autologous transfusion from 1992 to 1996 in the Alpes-Maritimes region].
    Ouzan D; Pesle B; Baldini E; Rimbourg H; Darphin F; Cohen N; Brichetti A; Follana R
    Gastroenterol Clin Biol; 2000 Mar; 24(3):337-41. PubMed ID: 10804343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.